Related Articles
Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer
Association of osteopontin and cyclooxygenase‑2 expression with breast cancer subtypes and their use as potential biomarkers
O6‑methylguanine‑DNA methyltransferase as a prognostic and predictive marker for basal‑like breast cancer treated with cyclophosphamide‑based chemotherapy
Stromal expression of matrix metalloproteinase 2 in cancer-associated fibroblasts is strongly related to human epidermal growth factor receptor 2 status in invasive breast carcinoma